MRI predictors of tumor-positive margins after breast-conserving surgery.


Journal

Clinical imaging
ISSN: 1873-4499
Titre abrégé: Clin Imaging
Pays: United States
ID NLM: 8911831

Informations de publication

Date de publication:
Historique:
received: 15 01 2019
revised: 19 04 2019
accepted: 14 05 2019
pubmed: 28 5 2019
medline: 9 1 2020
entrez: 26 5 2019
Statut: ppublish

Résumé

The purpose of this study is to identify predictors of tumor-positive surgical margins after breast-conserving surgery on dynamic contrast-enhanced (DCE) MRI. We conducted a retrospective study of consecutive women who underwent DCE MRI before breast-conserving surgery from 2005 to 2014. Patient demographics, indication for surgery, MRI findings, biopsy pathology results, and surgical outcomes were reviewed. The unpaired t-test and chi-square test were used to compare the positive and negative margins groups. 554 women (mean age, 56; range, 26-90) underwent DCE MRI before 575 breast-conserving surgeries for invasive carcinoma (n = 473) or ductal carcinoma in situ (DCIS) (n = 102). Positive margins requiring re-excision occurred in 19.7% (93/473) of surgeries for invasive carcinoma and 31.4% (32/102) of surgeries for DCIS. For invasive carcinoma surgeries, positive margins were more common when MRI demonstrated the finding of non-mass enhancement (NME) rather than the finding of enhancing mass (33.8% [22/65] versus 16.9% [61/360], p < 0.01). Tumor size on MRI was significantly larger in the positive margins group (2.5 cm versus 1.9 cm, p < 0.001). Positive margins were more common with invasive lobular rather than invasive ductal histology at core biopsy (38.3% [18/47] versus 16.0% [56/350], p < 0.001). For DCIS surgeries, there were no significant differences in positive margin rates related to MRI features. For invasive carcinoma surgeries, positive margins are associated with NME on MRI, larger tumor size on MRI, and lobular histology at core biopsy. These findings may be used to predict which patients are at risk for positive margins after breast-conserving surgery.

Identifiants

pubmed: 31128385
pii: S0899-7071(19)30094-4
doi: 10.1016/j.clinimag.2019.05.006
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

45-49

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Manisha Bahl (M)

Duke University Medical Center, Department of Radiology, DUMC Box 3808, Durham, NC 27710, United States of America. Electronic address: mbahl1@mgh.harvard.edu.

Jay A Baker (JA)

Duke University Medical Center, Department of Radiology, DUMC Box 3808, Durham, NC 27710, United States of America. Electronic address: jay.baker@duke.edu.

Emily N Kinsey (EN)

Duke University Medical Center, Department of Medicine, DUMC Box 3913, Durham, NC 27710, United States of America. Electronic address: emily.kinsey@duke.edu.

Sujata V Ghate (SV)

Duke University Medical Center, Department of Radiology, DUMC Box 3808, Durham, NC 27710, United States of America. Electronic address: sujata.ghate@duke.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH